Donor lymphoid organs are a major site of alloreactive T-cell priming following intestinal transplantation

American Journal of Transplantation

Volumn 6, Issue 11, 2006, Pages 2563-2571

  Wang, J ^a   Dong, Y ^a   Sun, J Z ^a   Taylor, R T ^a   Guo, C ^b   Alegre, M L ^c   Williams, I R ^a   Newell, K A ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

Cell trafficking; Rodent; T cells; Transplantation

Indexed keywords

GAMMA INTERFERON;

ALLOGRAFT; ALLOIMMUNITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DONOR LYMPHOID ORGAN; GRAFT REJECTION; IMMUNE RESPONSE; IMMUNOGENICITY; INTESTINE GRAFT; INTESTINE TRANSPLANTATION; LYMPH NODE; LYMPHOCYTE MIGRATION; LYMPHOCYTE PROLIFERATION; LYMPHOID ORGAN; MALE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RISK FACTOR; SPLENECTOMY; T LYMPHOCYTE;

ANIMALS; FLOW CYTOMETRY; GENOTYPE; GRAFT REJECTION; INTESTINES; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MODELS, ANIMAL; PEYER'S PATCHES; T-LYMPHOCYTES; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 33750024198     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2006.01516.x     Document Type: Article

References (22)

1. Zhang Z, Zhu L, Quan D et al. Pattern of liver, kidney, heart, and intestine allograft rejection in different mouse strain combinations. Transplantation 1996; 62: 1267-1272.
2. Grant D, Abu-Elmagd K, Reyes J et al. 2003 report of the intestine transplant registry: A new era has dawned. Ann Surg 2005; 241: 607-613.
3. 2004 Annual Report of the U.S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1994-2003. Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation, Rockville, MD; United Network for Organ Sharing, Richmond, VA; University Renal Research and Education Association, Ann Arbor, MI; 2004.
4. Krieger NR, Yin DP, Garrison Fathman C. CD4+ but not CD8+ cells are essential for allorejection. J Exp Med 1996; 184: 2013-2018.
5. He G, Hart J, Kim OS et al. The role of CD8 and CD4 T cells in intestinal allograft rejection: A comparison of monoclonal antibody-treated and knockout mice. Transplantation 1999; 67: 131-137.
6. Scornik JC, Soldevilla-Pico C, Van der Werf WJ et al. Susceptibility of liver allografts to high or low concentrations of preformed antibodies as measured by flow cytometry. Am J Transplant 2001; 1: 152-156.
7. Colvin RB, Smith RN. Antibody-mediated organ-allograft rejection. Nat Rev Immunol 2005; 5: 807-817.
8. Jones ND, Turvey SE, Van Maurik A et al. Differential susceptibility of heart, skin, and islet allografts to T cell-mediated rejection. J Immunol 2001; 166: 2824-2830.
9. Lakkis FG, Arakelov A, Konieczny BT, Inoue Y. Immunologic 'ignorance' of vascularized organ transplants in the absence of secondary lymphoid tissue. Nat Med 2000; 6: 686-688.
10. Zhou P, Hwang KW, Palucki D et al. Secondary lymphoid organs are important but not absolutely required for allograft responses. Am J Transplant 2003; 3: 259-266.
11. Kellersmann R, Ulrichs K, Kellersmann A, Thiede A. Intragraft distribution of lymphocytes expressing beta7 integrins after small bowel transplantation in mice. Transpl Immunol 2004; 13: 249-258.
12. Newell KA, He G, Hart J, Thistlethwaite JR, Jr. Treatment with either anti-CD4 or anti-CD8monoclonal antibodies blocks alphabeta T cell-mediated rejection of intestinal allografts in mice. Transplantation 1997; 64: 959-965.
13. Corry RJ, Winn HJ, Russell PS. Primarily vascularized allografts of hearts in mice. The role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation 1973; 16: 343-350.
14. Ruiz P, Bagni A, Brown R et al. Histological criteria for the identification of acute cellular rejection in human small bowel allografts: Results of the pathology workshop at the VIII International Small Bowel Transplant Symposium. Transplant Proc 2004; 36: 335-337.
15. Macpherson AJ, Uhr T. The donor splice site mutation in NFkappaB-inducing kinase of alymphoplasia (aly/aly) mice. Immunogenetics 2003; 54: 693-698. Epub 2002 Dec 3.
16. Hofer MJ, Finger C, Pagenstecher A. Molecular genotyping of the murine H-2K MHC class I allele. J Immunol Methods 2005; 302: 168-171.
17. Wang J, Guo Z, Dong Y et al. Role of 4-1BB in Allograft Rejection Mediated by CD8+ T Cells. Am J Transplant 2003; 3: 543-551.
18. Guo Z, Meng L, Kim O et al. CD8 T cell-mediated rejection of intestinal allografts is resistant to inhibition of the CD40/CD154 costimulatory pathway. Transplantation 2001; 71: 1351-1354.
19. Benichou G, Valujskikh A, Heeger PS. Contributions of direct and indirect T cell alloreactivity during allograft rejection in mice. J Immunol 1999; 162: 352-358.
20. Honjo K, Xu XY, Kapp JA, Bucy RP. Activation and migration of allo-peptide specific TCR transgenic T cells in cardiac allograft rejection. Cell Immunol 2004; 230: 44-55.
21. Tesar BM, Chalasani G, Smith-Diggs L, Baddoura FK, Lakkis FG, Goldstein DR. Direct antigen presentation by a xenograft induces immunity independently of secondary lymphoid organs. J Immunol 2004; 173: 4377-4386.
22. Li XC, Almawi W, Jevnikar A, Tucker J, Zhong R, Grant D. Allogeneic lymphocyte proliferation stimulated by small intestine-derived epithelial cells. Transplantation 1995; 60: 82-89.